STAGE IIIC GASTRIC CANCER AJCC V7
Clinical trials for STAGE IIIC GASTRIC CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC GASTRIC CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC GASTRIC CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets hard-to-treat stomach cancers
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation before and after surgery can help prevent stomach cancer from coming back. It is for people with specific genetic types of stomach cancer (mismatch repair deficient or Epst…
Matched conditions: STAGE IIIC GASTRIC CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Experimental pill aims to boost radiation against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it makes tumor cells more sensitive to radiation therapy. Nineteen participants with cancer…
Matched conditions: STAGE IIIC GASTRIC CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC